topotecan,ifosfamide
gsk
['sarcoma', 'reecur']
reecur ph iii of ifos vs. topo based chemo for recurrent ewing's sarcoma by prof. mccabe: trial closed early due to results 96% likely that ifos was better at time of close for efs (8 vs. 14%) 5 month difference in os (10.5 months vs. 15.4 mo) #asco22 
Med Onc, Director of Breast & GYN Research Program @ Sarah Cannon Research Institute #bcsm #gyncsm #WomenInMedicine USAF Wife, Mom to 2 girls, tweets are mine.